BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 11307324)

  • 1. [Viral hepatitis in hemodialysis patients].
    Yanai M
    Rinsho Byori; 2001 Mar; 49(3):249-53. PubMed ID: 11307324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C infection in dialysis patients in Israel.
    Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
    Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.
    Sauné K; Kamar N; Miédougé M; Weclawiak H; Dubois M; Izopet J; Rostaing L
    Nephrol Dial Transplant; 2011 Jul; 26(7):2309-16. PubMed ID: 21097646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occasional infection of hepatitis C virus occurring in haemodialysis units identified by serial monitoring of the virus infection.
    Iwasaki Y; Esumi M; Hosokawa N; Yanai M; Kawano K
    J Hosp Infect; 2000 May; 45(1):54-61. PubMed ID: 10833344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and epidemiological study on nosocomial transmission of HCV in hemodialysis patients in Brazil.
    Carneiro MA; Teles SA; Lampe E; Espírito-Santo MP; Gouveia-Oliveira R; Reis NR; Yoshida CF; Martins RM
    J Med Virol; 2007 Sep; 79(9):1325-33. PubMed ID: 17607790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit.
    Girou E; Chevaliez S; Challine D; Thiessart M; Morice Y; Lesprit P; Tkoub-Scheirlinck L; Soing-Altrach S; Cizeau F; Cavin C; André M; Dahmanne D; Lang P; Pawlotsky JM
    Clin Infect Dis; 2008 Sep; 47(5):627-33. PubMed ID: 18662134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Examination of HCV infection in hemodialysis patients with HCV-RNA assay using a magnetic extraction method (AmpliCap GT HCV MONITOR Test Kit v2.0 and AmpliCap GT HCV Specimen Preparation Kit v2.0)].
    Tanaka M; Fujiyama S; Tanaka M; Itoh K; Matsushita K; Hara M; Kuwahara K; Yasumoto N; Nishimura Y; Yoshimura N; Tomita K
    Nihon Jinzo Gakkai Shi; 2003; 45(2):91-7. PubMed ID: 12703404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods used to reduce the prevalence of hepatitis C in a dialysis unit.
    Hussein MM; Mooij JM
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):909-13. PubMed ID: 20814130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of hepatitis C virus transmission in hemodialysis].
    Jadoul M; Poignet JL
    Nephrologie; 1997; 18(7):307-8. PubMed ID: 9496573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis C virus infection in hemodialysis].
    Simon N
    Pathol Biol (Paris); 1995 Oct; 43(8):735-40. PubMed ID: 8745596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit.
    Hussein MM; Mooij JM; Hegazy MS; Bamaga MS
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):107-13. PubMed ID: 17237902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of detection and quantification of hepatitis C virus RNA in hemodialysis: proposal for a rational diagnostic strategy].
    Halfon P; Pol S; Sayada C; Izopet J; Rostaing L; Ouzan D
    Nephrologie; 1997; 18(2):53-8. PubMed ID: 9182234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence and incidence of hepatitis C seroconversion in patients on hemodialysis].
    Resić H; Sahović V; Mesić E; Leto E
    Acta Med Croatica; 2003; 57(1):39-42. PubMed ID: 12876861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of hepatitis C virus in hemodialysis patients: five years experience from a single center.
    Mohamed WZ
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):548-54. PubMed ID: 20427892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: a nationwide prospective study.
    Schneeberger PM; Keur I; van Loon AM; Mortier D; de Coul KO; van Haperen AV; Sanna R; van Der Heijden TG; van Den Hoven H; van Hamersvelt HW; Quint W; van Doorn LJ
    J Infect Dis; 2000 Nov; 182(5):1291-9. PubMed ID: 11023452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C infection among patients receiving hemodialysis].
    Kamar N; Izopet J; Rostaing L
    Nephrologie; 2003; 24(3):133-41. PubMed ID: 12814060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nosocomial transmission of hepatitis C virus in a Dutch dialysis center].
    Schneeberger PM; Doorenbos CJ; van der Vliet W; Bergervoet P; Quint W; van Doorn LJ
    Ned Tijdschr Geneeskd; 1999 Apr; 143(15):801-6. PubMed ID: 10347644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nosocomial transmission of the hepatitis C virus in hemodialysis: monitors, personnel, or both?].
    Arenas MD; Sánchez-Payá J; Muñoz C; Egea JJ; Martín F; Gil MT; Sarró F
    Nefrologia; 2001; 21(5):476-84. PubMed ID: 11795017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.